Yellow Card reporting added to second clinical software system

Source:
GOV UK
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
20 February 2017

Abstract

Healthcare professionals who use Vision can now report suspected adverse reactions to MHRA directly through their clinical software.